Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative physiological and metabolomic study of Hirschfeldia incana under short- and medium-term lead (Pb) stress.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2026
Same author

Natural deep eutectic solvents for stilbenoid extraction from vine by-products: Solubilization and extraction efficiency study.

Journal of chromatography. A·2026
Same author

Early root-root interactions weaken foliar defense responses against Septoria tritici blotch in a durum wheat varietal mixture.

Journal of experimental botany·2026
Same author

<sup>1</sup>H-NMR Analysis of Wine Metabolites: Method Development and Validation.

Molecules (Basel, Switzerland)·2026
Same author

<i>In vitro</i> production of (+)-catechin and (-)-epicatechin glucuronides to better understand the <i>in vivo</i> metabolism of a polyphenol-rich extract (Memophenol™).

Food & function·2025
Same author

Bioavailable human metabolites from TOTUM-448 (plant-based formulation) maintain liver cell functionality in a hyperlipidic context that drives MASLD onset.

Scientific reports·2025

Related Experiment Video

Updated: Jul 9, 2026

A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

New polyphenols active on beta-amyloid aggregation.

Céline Rivière1, Tristan Richard, Xavier Vitrac

  • 1Laboratoire de physique et biophysique, Institut des Sciences de Vigne et du Vin, Université de Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux cedex, France.

Bioorganic & Medicinal Chemistry Letters
|November 29, 2007
PubMed
Summary

Four novel polyphenols, including malvidin and curculigosides B and D, show promise as inhibitors of amyloid-beta peptide aggregation, potentially aiding Alzheimer's disease treatment. Molecules with a C(6)-linkers-C(6) structure may be effective fibril inhibitors.

More Related Videos

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
11:04

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast

Published on: June 23, 2018

Visualizing Axonal Growth Cone Collapse and Early Amyloid &#946; Effects in Cultured Mouse Neurons
06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Related Experiment Videos

Last Updated: Jul 9, 2026

A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
11:04

Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast

Published on: June 23, 2018

Visualizing Axonal Growth Cone Collapse and Early Amyloid &#946; Effects in Cultured Mouse Neurons
06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Area of Science:

  • Biochemistry
  • Neuroscience
  • Pharmacology

Background:

  • Alzheimer's disease is characterized by amyloid-beta peptide aggregation.
  • Polyphenols are being investigated for their therapeutic potential.
  • Identifying novel inhibitors is crucial for Alzheimer's disease treatment.

Purpose of the Study:

  • To screen new polyphenol classes for their ability to inhibit amyloid-beta peptide aggregation.
  • To identify novel polyphenol inhibitors for Alzheimer's disease.

Main Methods:

  • Testing various polyphenol classes against amyloid-beta peptide aggregation.
  • Evaluating the inhibitory effects of identified compounds on fibril formation.

Main Results:

  • Four novel polyphenols, malvidin, its glucoside, curculigoside B, and curculigoside D, were identified as efficient fibril inhibitors.
  • The C(6)-linkers-C(6) structural motif was suggested as a key feature for potent inhibition.
  • Anti-amyloidogenic effects against amyloid-beta (1-40) and (1-42) peptides may involve multiple binding sites.

Conclusions:

  • Malvidin, its glucoside, curculigoside B, and curculigoside D are promising therapeutic leads for Alzheimer's disease.
  • The C(6)-linkers-C(6) structure is a potential target for designing new anti-amyloidogenic compounds.
  • Further research into the binding mechanisms of these polyphenols is warranted.